Wang S C, Greenwald G S
Biol Reprod. 1985 Aug;33(1):201-11. doi: 10.1095/biolreprod33.1.201.
Injecting 2 or 4 mg of cycloheximide (cyclo) at the onset of the proestrous release of gonadotropins prolongs the estrogen (E2) surge, diminishes progesterone (P4) secretion, and prevents ovulation by 0900 h of the next morning (Saidapur and Greenwald, 1981). The present study was designed to determine the effects of 0, 2, 4, or 8 mg cyclo injected at 1400 h proestrus (Day 4) on ovarian protein synthesis and other parameters. Ovulation was delayed until 1400 h estrus by 2 mg cyclo or prevented by 8 mg, and the latter treatment resulted in the death of all animals by 48 h. After 4 mg cyclo, ovulation was delayed in some animals, but the most characteristic feature was the development of large cystic follicles that ultimately transformed into corpora hemorrhagica. All animals lived after the injection of 4 mg cyclo. Ovaries collected 2, 8, 16, or 24 h after treatment were incubated with [3H]leucine for 1 h to assess the effects of cyclo on protein synthesis. Injection of phenobarbital at 1300 h proestrus, which blocks follicle-stimulating hormone (FSH) and luteinizing hormone (LH) surges, reduced ovarian protein synthesis at 1600 h to 61% of the control value. The incorporation of [3H]leucine was reduced to 75%, 37%, and 35% of the 1600-h control value by 2, 4, and 8 mg cyclo, respectively, but without affecting surge levels of FSH and LH. However, by 0600 h estrus, protein synthesis was increased significantly in all the cyclo-treated groups, which provides insight into the half-life of the compound (approximately equal to 8 h for 2-4 mg cyclo). At 1600 and 2200 h proestrus cyclo resulted in serum FSH and LH levels similar to controls, but increased serum prolactin and prolonged E2 levels at Day 4 of 2200 h and decreased serum P4 at both times. The second surge in FSH, which is in progress by 0600 h estrus, was abolished by 4 or 8 mg cyclo but not by the 2-mg dose. This is the first time for any species that ovarian protein synthesis has been measured in the proestrous normal or cyclo-treated animal. We conclude for the hamster that 4 mg cyclo is the optimal dose for blocking ovarian protein synthesis and ovulation and inducing formation of cystic follicles.
在促性腺激素发情前期释放开始时注射2或4毫克放线菌酮(环己酰亚胺)可延长雌激素(E2)高峰,减少孕酮(P4)分泌,并在下一早晨0900时前阻止排卵(赛达普尔和格林沃尔德,1981年)。本研究旨在确定在发情前期(第4天)1400时注射0、2、4或8毫克放线菌酮对卵巢蛋白质合成及其他参数的影响。2毫克放线菌酮可将排卵延迟至发情期1400时,8毫克则可阻止排卵,且后一种处理导致所有动物在48小时内死亡。注射4毫克放线菌酮后,部分动物排卵延迟,但最显著的特征是形成大的囊性卵泡,最终转变为出血性黄体。注射4毫克放线菌酮后所有动物均存活。处理后2、8、16或24小时采集的卵巢与[3H]亮氨酸一起孵育1小时,以评估放线菌酮对蛋白质合成的影响。在发情前期1300时注射苯巴比妥可阻断促卵泡激素(FSH)和促黄体生成素(LH)高峰,使1600时的卵巢蛋白质合成降至对照值的61%。2、4和8毫克放线菌酮分别使[3H]亮氨酸掺入量降至1600时对照值的75%、37%和35%,但不影响FSH和LH的高峰水平。然而,到发情期0600时,所有放线菌酮处理组的蛋白质合成均显著增加,这有助于了解该化合物的半衰期(2 - 4毫克放线菌酮约为8小时)。在发情前期1600和2200时,放线菌酮使血清FSH和LH水平与对照相似,但在2200时第4天血清催乳素增加、E2水平延长,且两个时间点血清P4均降低。在发情期0600时正在进行的FSH第二次高峰被4或8毫克放线菌酮消除,但2毫克剂量则无此作用。这是首次在任何物种中对发情前期正常或经放线菌酮处理的动物的卵巢蛋白质合成进行测量。我们得出结论,对于仓鼠而言,4毫克放线菌酮是阻断卵巢蛋白质合成和排卵以及诱导囊性卵泡形成的最佳剂量。